These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 177945)

  • 21. Interferon induction: hyporesponsiveness and prostaglandins.
    Stringfellow DA
    Tex Rep Biol Med; 1981-1982; 41():116-21. PubMed ID: 6184794
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pharmacological aspects of the prostaglandins].
    Weeks JR
    Minerva Ginecol; 1974 Jun; 26(6):321-7. PubMed ID: 4367819
    [No Abstract]   [Full Text] [Related]  

  • 23. Interactions between prostaglandins, muscarinic agonists and the adenylate cyclase and phospholipase C systems in dog ciliary smooth muscle.
    Abdel-Latif AA; Yousufzai SY; Ye Z
    Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():505-12. PubMed ID: 7732898
    [No Abstract]   [Full Text] [Related]  

  • 24. [Mechanism of thrombocyte aggregation inhibition caused by sulfonylurea compounds. 3. Significance of prostaglandins and cAMP for aggregation inhibiting effect and other effects of sulfonylurea compounds].
    Scholz VC; Hoder A; Losert W
    Arzneimittelforschung; 1975 Mar; 25(3):347-61. PubMed ID: 239727
    [No Abstract]   [Full Text] [Related]  

  • 25. [Relationship between the tonus of the walls of the internal carotid artery and cyclic adenylmonophosphate].
    Mchedlishvili GI; Ormotsadze LG
    Biull Eksp Biol Med; 1980 Oct; 90(10):393-5. PubMed ID: 6252982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hypothesis of the key coordinating role of adenylate cyclase signal mechanism and cAMP in regulatory effect of insulin superfamily peptides on fundamental cellular processes: cell growth, apoptosis, metabolism (Development of the L. G. Leĭbson's works)].
    Pertseva MN
    Zh Evol Biokhim Fiziol; 2000; 36(6):494-503. PubMed ID: 11212527
    [No Abstract]   [Full Text] [Related]  

  • 27. Local regulation of lipolysis in adipose tissue by fatty acids, prostaglandins and adenosine.
    Fredholm BB
    Med Biol; 1978 Oct; 56(5):249-61. PubMed ID: 213661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Adenyl cyclase and cyclic adenosine-3',5'-monophosphate].
    Jurkowski A; Kański M
    Postepy Hig Med Dosw; 1973; 27(3):329-40. PubMed ID: 4352820
    [No Abstract]   [Full Text] [Related]  

  • 29. Prostaglandins and inflammation: receptor/cyclase coupling as an explanation of why PGEs and PGI2 inhibit functions of inflammatory cells.
    Weissmann G; Smolen JE; Korchak H
    Adv Prostaglandin Thromboxane Res; 1980; 8():1637-53. PubMed ID: 6246786
    [No Abstract]   [Full Text] [Related]  

  • 30. Cyclic AMP turnover in response to prostaglandins in intact platelets: evidence for separate stimulatory and inhibitory prostaglandin receptors.
    Ashby B
    Second Messengers Phosphoproteins; 1988; 12(1):45-57. PubMed ID: 2848122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucagon and prostaglandin E1 stimulation of cyclic adenosine 3', 5'-monophosphate levels and adenylate cyclase activity in benign hyperplastic nodules and malignant hepatomas of ethionine-treated rats.
    Chayoth R; Epstein SM; Field JB
    Cancer Res; 1973 Aug; 33(8):1970-4. PubMed ID: 4352743
    [No Abstract]   [Full Text] [Related]  

  • 32. The immediate allergic response: in vitro action of cyclic AMP-active and other drugs on the two stages of histamine release.
    Lichtenstein LM; DeBernardo R
    J Immunol; 1971 Oct; 107(4):1131-6. PubMed ID: 4106092
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of vasopressin and prostaglandin E 1 on the adenyl cyclase-cyclic 3',5'-adenosine monophosphate system of the renal medulla of the rat.
    Beck NP; Kaneko T; Zor U; Field JB; Davis BB
    J Clin Invest; 1971 Dec; 50(12):2461-5. PubMed ID: 4331595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostaglandins and the thyroid gland.
    Mashiter K; Field JB
    Fed Proc; 1974 Jan; 33(1):78-80. PubMed ID: 4359039
    [No Abstract]   [Full Text] [Related]  

  • 35. [Problems of the pathogenesis of arteriosclerosis].
    Gerasimova EN
    Ter Arkh; 1975; 47(7):15-24. PubMed ID: 178063
    [No Abstract]   [Full Text] [Related]  

  • 36. [Mechanism of action of prostaglandins].
    Nouv Presse Med; 1975 Dec; 4(43):3087. PubMed ID: 177945
    [No Abstract]   [Full Text] [Related]  

  • 37. Interaction of prostaglandins and histamine with enzymes of cyclic AMP metabolism from guinea pig gastric mucosa.
    Wollin A; Code CF; Dousa TP
    J Clin Invest; 1976 Jun; 57(6):1548-53. PubMed ID: 180055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On the mechanisms of the growth-promoting effect of prostaglandins in hepatocytes: the relationship between stimulation of DNA synthesis and signaling mediated by adenylyl cyclase and phosphoinositide-specific phospholipase C.
    Refsnes M; Dajani OF; Sandnes D; Thoresen GH; Røttingen JA; Iversen JG; Christoffersen T
    J Cell Physiol; 1995 Sep; 164(3):465-73. PubMed ID: 7650056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of cyclic AMP metabolism in human platelets. Sequential activation of adenylate cyclase and cyclic AMP phosphodiesterase by prostaglandins.
    Alvarez R; Taylor A; Fazzari JJ; Jacobs JR
    Mol Pharmacol; 1981 Sep; 20(2):302-9. PubMed ID: 6272089
    [No Abstract]   [Full Text] [Related]  

  • 40. On the relation of cyclic AMP to adrenergic receptors and sympathin.
    Robinson GA; Sutherland EW
    Adv Cytopharmacol; 1971 May; 1():263-72. PubMed ID: 4149853
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.